169 related articles for article (PubMed ID: 16927740)
21. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
Chambers MS; Posner M; Jones CU; Biel MA; Hodge KM; Vitti R; Armstrong I; Yen C; Weber RS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1102-9. PubMed ID: 17379432
[TBL] [Abstract][Full Text] [Related]
22. Effect of cevimeline on salivary components in patients with Sjögren syndrome.
Suzuki K; Matsumoto M; Nakashima M; Takada K; Nakanishi T; Okada M; Ohsuzu F
Pharmacology; 2005 May; 74(2):100-5. PubMed ID: 15722648
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of pilocarpine and cevimeline on salivary flow.
Braga MA; Tarzia O; Bergamaschi CC; Santos FA; Andrade ED; Groppo FC
Int J Dent Hyg; 2009 May; 7(2):126-30. PubMed ID: 19416095
[TBL] [Abstract][Full Text] [Related]
24. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia.
Jacobs CD; van der Pas M
Oncology (Williston Park); 1996 Mar; 10(3 Suppl):16-20. PubMed ID: 8723429
[TBL] [Abstract][Full Text] [Related]
25. Effects of cevimeline on salivation and thirst in conscious rats.
Sato N; Ono K; Haga K; Yokota M; Inenaga K
Arch Oral Biol; 2007 Jan; 52(1):26-9. PubMed ID: 17049480
[TBL] [Abstract][Full Text] [Related]
26. Assessing salivary gland hypofunction--Part two.
Muzyka BC
Pract Proced Aesthet Dent; 2002 Apr; 14(3):262. PubMed ID: 12004635
[No Abstract] [Full Text] [Related]
27. Effect of cevimeline on radiation-induced salivary gland dysfunction and AQP5 in submandibular gland in mice.
Takakura K; Takaki S; Takeda I; Hanaue N; Kizu Y; Tonogi M; Yamane GY
Bull Tokyo Dent Coll; 2007 May; 48(2):47-56. PubMed ID: 17978545
[TBL] [Abstract][Full Text] [Related]
28. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacological and clinical profile of pilocarpine hydrochloride (SALAGEN) Tab. 5 mg)].
Maruyama K; Koshihara N
Nihon Yakurigaku Zasshi; 2006 May; 127(5):399-407. PubMed ID: 16819247
[No Abstract] [Full Text] [Related]
30. Salivary hypofunction and xerostomia: diagnosis and treatment.
Atkinson JC; Grisius M; Massey W
Dent Clin North Am; 2005 Apr; 49(2):309-26. PubMed ID: 15755407
[TBL] [Abstract][Full Text] [Related]
31. Effect of 0.1% pilocarpine mouthwash on xerostomia: double-blind, randomised controlled trial.
Kim JH; Ahn HJ; Choi JH; Jung DW; Kwon JS
J Oral Rehabil; 2014 Mar; 41(3):226-35. PubMed ID: 24527846
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and economic evaluation of pilocarpine in treating radiation-induced xerostomia.
Taylor SE
Expert Opin Pharmacother; 2003 Sep; 4(9):1489-97. PubMed ID: 12943478
[TBL] [Abstract][Full Text] [Related]
33. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
Fife RS; Chase WF; Dore RK; Wiesenhutter CW; Lockhart PB; Tindall E; Suen JY
Arch Intern Med; 2002 Jun; 162(11):1293-300. PubMed ID: 12038948
[TBL] [Abstract][Full Text] [Related]
34. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
[TBL] [Abstract][Full Text] [Related]
35. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer.
Taweechaisupapong S; Pesee M; Aromdee C; Laopaiboon M; Khunkitti W
Aust Dent J; 2006 Dec; 51(4):333-7. PubMed ID: 17256309
[TBL] [Abstract][Full Text] [Related]
37. Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma.
Hamlar DD; Schuller DE; Gahbauer RA; Buerki RA; Staubus AE; Hall J; Altman JS; Elzinga DJ; Martin MR
Laryngoscope; 1996 Aug; 106(8):972-6. PubMed ID: 8699911
[TBL] [Abstract][Full Text] [Related]
38. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
Nusair S; Rubinow A
Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
[TBL] [Abstract][Full Text] [Related]
39. Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.
Chambers MS; Keene HJ; Toth BB; Lemon JC; Gallagher SC; Martin CG; Martin JW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):180-4. PubMed ID: 15660089
[TBL] [Abstract][Full Text] [Related]
40. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Nieuw Amerongen AV; Veerman EC
Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]